• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然和非糖基化重组单链尿激酶型纤溶酶原激活剂被大鼠肝实质细胞上不同的受体系统识别。

Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.

作者信息

van der Kaaden M E, Rijken D C, Groeneveld E, van Berkel T J, Kuiper J

机构信息

Division of Biopharmaceutics, Sylvius Laboratory, Leiden/Amsterdam Center for Drug Research, University of Leiden, The Netherlands.

出版信息

Thromb Haemost. 1995 Aug;74(2):722-9.

PMID:8585013
Abstract

The recognition systems mediating the clearance of glycosylated high molecular weight single-chain urokinase-type plasminogen activator (HMW-scu-PA, produced in human embryonic kidney cells) and recombinant non-glycosylated scu-PA (rscu-PA, produced in E. coli) were analyzed by studying their binding characteristics to freshly isolated rat parenchymal liver cells. The binding of 125I-HMW-scu-PA at 4 degrees C was calcium-dependent and of high affinity (Kd = 37.6 nM) and could be inhibited by low molecular weight two-chain u-PA (LMW-tcu-PA) and lactose, but not by the low density lipoprotein receptor-related protein (LRP)-associated 39-kDa protein (RAP), rscu-PA or a mutant form lacking amino acids 11-135 (Delta 125-rscu-PA). Removal of the carbohydrate side chain of HMW-scu-PA by treatment with N-glycosidase F, completely reduced the specific binding to the parenchymal cells and strongly reduced its competition with 125I-HMW-scu-PA in cell binding. Recombinant scu-PA also bound with high affinity (Kd = 38.7 nM) to the parenchymal liver cells. The binding of 125I-rscu-PA could be competed for by unlabeled rscu-PA while Delta 125-rscu-PA, LMW-tcu-PA or lactose were ineffective. In contrast to HMW-scu-PA, binding of 125I-rscu-PA could be effectively inhibited by RAP (Ki = 1.1 nM), while also its association and degradation, as determined at 37 degrees C, were inhibited by RAP. Pretreatment of the parenchymal cells with proteinase K supplied further evidence for the involvement of two different receptor systems.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过研究糖基化高分子量单链尿激酶型纤溶酶原激活剂(HMW - scu - PA,在人胚肾细胞中产生)和重组非糖基化scu - PA(rscu - PA,在大肠杆菌中产生)与新鲜分离的大鼠肝实质细胞的结合特性,分析了介导其清除的识别系统。4℃下125I - HMW - scu - PA的结合是钙依赖性的且具有高亲和力(Kd = 37.6 nM),可被低分子量双链u - PA(LMW - tcu - PA)和乳糖抑制,但不能被低密度脂蛋白受体相关蛋白(LRP)相关的39 kDa蛋白(RAP)、rscu - PA或缺乏氨基酸11 - 135的突变形式(Δ125 - rscu - PA)抑制。用N - 糖苷酶F处理去除HMW - scu - PA的碳水化合物侧链,完全降低了与实质细胞的特异性结合,并强烈降低了其在细胞结合中与125I - HMW - scu - PA的竞争能力。重组scu - PA也以高亲和力(Kd = 38.7 nM)与肝实质细胞结合。125I - rscu - PA 的结合可被未标记的rscu - PA竞争,而Δ125 - rscu - PA、LMW - tcu - PA或乳糖则无效。与HMW - scu - PA不同,125I - rscu - PA的结合可被RAP有效抑制(Ki = 1.1 nM),同时其在37℃下的结合和降解也被RAP抑制。用蛋白酶K预处理实质细胞为两种不同受体系统的参与提供了进一步证据。(摘要截短于250字)

相似文献

1
Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.天然和非糖基化重组单链尿激酶型纤溶酶原激活剂被大鼠肝实质细胞上不同的受体系统识别。
Thromb Haemost. 1995 Aug;74(2):722-9.
2
The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.低密度脂蛋白受体相关蛋白(LRP)在大鼠体内重组单链尿激酶型纤溶酶原激活剂的血浆清除及肝脏摄取中的作用
Thromb Haemost. 1997 Apr;77(4):710-7.
3
Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).基质溶解素-1(MMP-3)对尿激酶型纤溶酶原激活剂的蛋白水解切割
Biochemistry. 1998 May 19;37(20):7231-6. doi: 10.1021/bi9728708.
4
Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.纤溶酶原激活物抑制剂1含有一个隐蔽的高亲和力受体结合位点,该位点在与组织型纤溶酶原激活物形成复合物时暴露出来。
Thromb Haemost. 1998 Nov;80(5):822-8.
5
Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.人单链尿激酶与中国仓鼠卵巢细胞的结合及仓鼠尿激酶型纤溶酶原激活物受体的克隆
Thromb Haemost. 1998 Jul;80(1):148-54.
6
Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.低分子量和高分子量单链尿激酶型纤溶酶原激活剂的体外纤溶活性比较
Thromb Haemost. 1993 Sep 1;70(3):481-5.
7
Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).组织型纤溶酶原激活剂与尿激酶型纤溶酶原激活剂重组嵌合体(rt-PA/u-PA)的结构域缺失和/或重复突变体的特性分析
Thromb Haemost. 1990 Aug 13;64(1):53-60.
8
In vivo and in vitro interaction of high and low molecular weight single-chain urokinase-type plasminogen activator with rat liver cells.
J Biol Chem. 1992 Jan 25;267(3):1589-95.
9
An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA.
Thromb Haemost. 1992 Jan 23;67(1):95-100.
10
Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.组织型纤溶酶原激活剂与1型纤溶酶原激活剂抑制剂复合物与大鼠肝细胞相互作用的表征
Thromb Haemost. 1995 Nov;74(5):1298-304.

引用本文的文献

1
Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time.人乙酰胆碱酯酶上N-糖基化靶点的过载与去除:对聚糖组成和循环停留时间的影响
Biochem J. 2002 May 1;363(Pt 3):619-31. doi: 10.1042/0264-6021:3630619.